Hong Kong Stock Movement | WuXi Biologics (02269.HK) Rises Over 4% on Securing Largest Biosimilar Development Order; UBS Gives Target Price of HK$62

Zhitong Finance APP has learned that WuXi Biologics (02269.HK) rose more than 4%. As of press time, it was up 4.13% at HK$44.84, with a turnover of HK$265 million.